Michael J. Fox Foundation for Parkinson’s Research: Inflammation Biomarkers for Parkinson’s Disease

The Michael J. Fox Foundation for Parkinson’s Research seeks to support research that will develop new or improve upon existing biomarker tools for neuroinflammation/peripheral inflammation in Parkinson’s disease (PD). The specific goals of this initiative are to:

  1. facilitate the development of biomarker measures that can be utilized for novel target validation,
  2. assess pathological progression or phenoconversion, or
  3. identify inflammation paradigms unique to PD.

Proposed biomarkers should facilitate objective decisions to validate a particular target or target efficacy marker (downstream readouts of successful target modification), improve the ability to enrich subject populations in clinical trials and/or determine whether experimental treatments are modifying the course of the disease, its symptoms, or its progression.

Funding & Duration

1-2 year grants are available, for up to USD $300,000 (approx AUD $393,600)


Applications are encouraged from: U.S. and non-U.S. biotechnology/pharmaceutical companies or other for-profit entities, either publicly or privately held; and U.S. and non-U.S. entities, public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government.

Post-doctoral fellows are not eligible to apply as principal investigators to this program.

Submission Requirements & Due Dates

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences. Bookmark the permalink.

Comments are closed.